Optimizing Patient's Comfort During Scleral Indentation

NCT06683209 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2025-08-01

No results posted yet for this study

Summary

The scleral depression exam is an important routine technique for evaluating the retinal periphery for various reasons. During this examination, an instrument is used to bring the anterior part of the retina into the physician's field of view. The downside of this technique is the discomfort it may cause the patient. Different instruments can be used to depress the sclera.

The objective of this research is to compare three commonly used scleral depressors based on their performance for the ophthalmologist and the discomfort they subjectively induce in patients.

Patients will be randomly allocated to one of three examination groups:

Group A: One eye examined with the Schocket scleral depressor, the other eye with the Josephberg-Besser scleral depressor.

Group B: One eye examined with the Schocket scleral depressor, the other eye with the cotton-tip applicator.

Group C: One eye examined with the cotton-tip applicator, the other eye with the Josephberg-Besser scleral depressor.

Conditions

Interventions

DIAGNOSTIC_TEST

Schocket scleral depressor

Use of this instrument to examine one eye

DIAGNOSTIC_TEST

Josephberg-Besser

Use of this instrument to examine one eye

DIAGNOSTIC_TEST

Cotton tip applicator

Use of this instrument to examine one eye

Sponsors & Collaborators

  • University of Toronto

    collaborator OTHER
  • Alberta Retina Consultant

    collaborator UNKNOWN
  • University of Alberta

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-07-01
Primary Completion
2026-07-30
Completion
2026-07-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06683209 on ClinicalTrials.gov